BRIEF-Anika Therapeutics expects to complete supplemental phase III trial of CINGAL in 2018
May 25, 2017 at 13:40 PM EDT
* Anika announces first patient enrolled in supplemental phase III trial of CINGAL for the treatment of knee pain associated with osteoarthritis